Regarding the adjuvant, we previously showed that GLA-SE adjuvanted FILORAB1 rabies virus-based EBOLA vaccine, protected 100% of NHPs challenged with Ebola, an improvement from the unadjuvanted FILORAB1 vaccine, which was less protective. Here, GLA is linked to Ebola hemorrhagic fever.